Literature DB >> 16412798

Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes.

L Swan1, C Varma, J Yip, M Warr, G Webb, L Benson, P McLaughlin.   

Abstract

BACKGROUND: Device closure of an atrial septal defect (ASD) results in symptom-reduction, right heart remodelling and lower pulmonary artery pressures. However it is unclear if there is a chronological limit to these benefits and whether device closure is safe in elderly subjects. The aim of this study was, therefore, to assess the safety and efficacy of device closure in patients >60 years.
METHODS: Retrospective study of Amplatzer Septal Occluder device closures from a single institution (May 1999-August 2002).
RESULTS: Fifty subjects aged >60 years (range 60-85 years) had ASD device closure (27% of the total cohort). Defect size and shunt size were similar for both younger and older groups (2.2:1 in both groups, p=0.9) as were procedural duration, fluoroscopy time and device size deployed. Baseline right ventricular (RV) systolic pressure ((younger vs. older) 39 vs. 49 mmHg, p<0.001) and right ventricular size (45 vs. 51 mm, p<0.001) were greater in the older group. Following closure RV systolic pressure (49 vs. 45 mmHg, p<0.01) and RV size (51 vs. 44 mm, p=0.01) decreased in the older group.
CONCLUSION: Device closure of an ASD can be performed safely in older patients. The right heart shows signs of remodelling even in elderly subjects.

Entities:  

Mesh:

Year:  2006        PMID: 16412798     DOI: 10.1016/j.ijcard.2005.03.027

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

1.  Percutaneous device closure of secundum atrial septal defect in older adults.

Authors:  Hossein Dehghani; Andrew J Boyle
Journal:  Am J Cardiovasc Dis       Date:  2012-05-15

2.  Mid-to-long-term follow-up results of transcatheter closure of atrial septal defect in patients older than 40 years.

Authors:  Jou-Kou Wang; Shuenn-Nan Chiu; Ming-Tai Lin; Chun-An Chen; Chun-Wei Lu; Mei-Hwan Wu
Journal:  Heart Vessels       Date:  2016-08-16       Impact factor: 2.037

3.  Benefit of atrial septal defect closure in adults: impact of age.

Authors:  Michael Humenberger; Raphael Rosenhek; Harald Gabriel; Florian Rader; Maria Heger; Ursula Klaar; Thomas Binder; Peter Probst; Georg Heinze; Gerald Maurer; Helmut Baumgartner
Journal:  Eur Heart J       Date:  2010-10-12       Impact factor: 29.983

4.  ASD closure under pressure.

Authors:  Suhair Omar Shebani; Gregory James Skinner; Christopher Duke
Journal:  BMJ Case Rep       Date:  2014-09-11

5.  Comparison of the response of the right ventricle with endovascular occlusion and surgical closure in adults with atrial septal defect one year after intervention.

Authors:  Niloufar Samiei; Fariba Bayat; Masoud Moradi; Mozhgan Parsaei; Seyedeh Zahra Ojaghi Haghighi; Ahmad Mohebbi; Negar Hamzepour; Fereidoon Noohi
Journal:  Clin Med Insights Cardiol       Date:  2010-12-20

6.  Transcatheter closure of atrial septal defect: does age matter?

Authors:  Nam Kyun Kim; Su-Jin Park; Jae Young Choi
Journal:  Korean Circ J       Date:  2011-11-29       Impact factor: 3.243

7.  Transcatheter closure of secundum atrial septal defect in patients over 60 years old.

Authors:  Jae Young Choi
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243

8.  Transcatheter closure of secundum atrial septal defect in patients over 60 years old.

Authors:  Saet Byul Woo; So-Ick Jang; Seong-Ho Kim; Soo-Jin Kim; Sang-Yun Lee; Jae-Sook Baek; Woo-Sup Shim
Journal:  Korean Circ J       Date:  2013-02-28       Impact factor: 3.243

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.